**
Recent research indicates that fetuses may be exposed to significantly higher concentrations of per- and polyfluoroalkyl substances (PFAS), commonly referred to as “forever chemicals,” than previously understood. A comprehensive study conducted by Mount Sinai examined umbilical cord blood samples and discovered 42 distinct PFAS compounds, raising alarming questions about the implications for fetal health.
Groundbreaking Findings from Mount Sinai Research
Traditionally, tests of umbilical cord blood have focused on a limited array of PFAS compounds, primarily perfluorooctanoic acid (PFOA) and perfluorooctane sulfonate (PFOS). However, this new investigation utilised an advanced non-targeted analysis approach, which allowed researchers to identify a broader spectrum of PFAS compounds across 120 samples that had previously registered only a handful. The findings revealed a concerning increase in the total levels of these substances in fetal blood, suggesting that infants are exposed to a wider array of PFAS than previously acknowledged.
Shelley Liu, an associate professor at the Icahn School of Medicine at Mount Sinai and co-author of the study, stressed the importance of these findings. “Babies are exposed to many more PFAS than we previously thought,” she remarked, highlighting the critical vulnerability of fetuses during this developmental stage.
Understanding PFAS and Their Health Implications
PFAS encompass a class of approximately 15,000 synthetic chemicals, widely used for their water-, stain-, and grease-resistant properties. An extensive body of research has linked these compounds to numerous health issues, including various cancers, birth defects, compromised immune systems, elevated cholesterol levels, and kidney disease. Dubbed “forever chemicals,” PFAS are notorious for their persistence in the environment and human body, resisting natural decomposition.
A review of 40 studies revealed that PFAS have been detected in every one of the 30,000 umbilical cord blood samples analysed. Elevated PFAS levels in expectant mothers correlate with adverse outcomes, such as increased infant mortality and low birth weight, which can lead to obesity and other health complications later in life. Furthermore, prenatal exposure has been associated with a heightened risk of developing cancer, neurological disorders, and cardiovascular diseases in later stages of life.
Regulatory Challenges and Rising Concerns
The legacy PFAS compounds, including PFOA and PFOS, have been largely phased out over the past decade. In their place, manufacturers have introduced newer generations of PFAS, which they claim to be less toxic, although such assertions often lack robust scientific backing. Compounding the issue, the ability of regulatory bodies to monitor these emerging PFAS compounds has not kept pace with their proliferation. For instance, the United States Environmental Protection Agency (EPA) typically employs testing methods that identify only around 30-40 PFAS compounds, despite independent studies uncovering thousands of PFAS in environmental samples.
The Mount Sinai study effectively contrasted traditional analysis methods with the more comprehensive non-targeted approach. Liu indicated that this expanded testing revealed numerous additional PFAS compounds, with 31 detected that are not included in the EPA’s certified blood tests for 53 specific PFAS.
Future Directions: Understanding Health Impacts
Although the Mount Sinai study did not directly assess the health consequences of the elevated PFAS levels identified, Liu acknowledged the ambiguity surrounding their potential impacts. Generally, increased concentrations of PFAS in blood are linked to heightened health risks.
The blood samples analysed were collected as part of a federal initiative known as the Home Study, which tracks PFAS exposure and its effects on health throughout a person’s life. The researchers at Mount Sinai are expected to delve deeper into the health implications of their findings in future studies.
David Andrews, acting chief science officer at the Environmental Working Group, underscored the significance of this research, stating that the study reveals how the true extent of harm to infants, affected by a diverse mix of PFAS chemicals, has likely been underestimated due to inadequate measurement capabilities. Andrews further noted that the findings serve as a critical reminder of the urgent need for stringent health-protective regulations to avert the risk of infants being born contaminated with hazardous substances like PFAS.
Why it Matters
This study sheds light on a pressing public health issue, emphasising the need for improved regulatory frameworks to protect vulnerable populations, particularly unborn children, from toxic chemical exposure. As awareness of the widespread presence of PFAS in the environment grows, so too does the imperative for comprehensive research and proactive measures to ensure the wellbeing of future generations. The implications of these findings extend far beyond the laboratory, signalling a call to action for policymakers, health professionals, and society at large to confront the challenges posed by these persistent pollutants.
